← Back to Dashboard

Simnotrelvir

3CL protease inhibitor

2D Structure

Structure not available

3D Structure

Loading 3D structure...

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
China
Phase 3 ref (nejm.org) Approval ref (english.nmpa.gov.cn) Simcere Pharmaceuticalbrand Xiannuoxin (先诺欣)NMPA conditional approval Jan 2023co-administered with ritonavir